To Participate on Thurstonblog

email yyyyyyyyyy58@gmail.com, provide profile information and we'll email your electronic membership


Tuesday, September 22, 2015

Martin Shkreli will never be named philanthropist of the year, not with his drug price hike of 5000% (even though he has now dropped the price).

...................................................................................................................................................................
COMMENTS:
*  There's a special place in hell for people like this.
*  And you wonder why all the other industrial nations have universal socialized healthcare AND pay far less then we do.
*  Typical righty corporate criminal. You want more of this, vote republican. They'd love to kill your parents.
*  I'm not a big fan of Hillary, but she's right on this. Drug companies are ripping off American consumers.
*  This is another example of capitalism at its worst. Drug companies can charge what they like and the government does nothing to rein them in. Look at Medicare -- it is not allowed BY LAW to negotiate to reduce prices with Big Pharma. Congress favored the corporations over the citizens of America. Disgraceful. Expect more until enough groups and individuals agitate against this kind of thing and lawmakers are forced to act for the good of the people.
...................................................................................................................................................................
Turing says it will rescind part of 5,000% price hike on toxoplasmosis drug
By Beth Braverman, September 21, 2015

The company that sparked an angry backlash after it raised the price of a drug for treating a deadly parasitic infection by more than 5,000 percent says it will roll back some of the increase.

Turing Pharmaceuticals CEO Martin Shkreli told ABC News on Tuesday that the new price would make Daraprim more accessible, although he did not say what the new price for the drug would be. A spokesman for Turing did not immediately respond to a request for details.

"We've agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit," Shkreli told ABC.

The company obtained rights to sell the drug, the only U.S.-approved treatment for toxoplasmosis, in August. It hiked the price overnight from $13.50 per pill to $750.

Turing had said it would use profits to improve the drug's formulation and develop new, better drugs for the infection. It also stressed that some patients can get financial aid from the company to obtain the drug.

But the price hike sparked outrage from medical groups representing doctors who care for patients with HIV and other infectious diseases, because Daraprim treats patients with compromised immune systems.

Hillary Rodham Clinton called Turing's price hike "outrageous" in a tweet Monday. While campaigning for the Democratic nomination for president Tuesday, she outlined a broad plan aimed at holding down the cost of prescription drugs.
...................................................................................................................................................................

No comments: